Trexquant Investment’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.6M | Buy |
456,987
+220,504
| +93% | +$6.1M | 0.14% | 192 |
|
|
2025
Q1 | $5.25M | Buy |
236,483
+155,641
| +193% | +$3.46M | 0.06% | 486 |
|
|
2024
Q4 | $1.6M | Sell |
80,842
-74,350
| -48% | -$1.47M | 0.02% | 946 |
|
|
2024
Q3 | $3.88M | Sell |
155,192
-46,523
| -23% | -$1.16M | 0.05% | 574 |
|
|
2024
Q2 | $3.77M | Buy |
201,715
+127,809
| +173% | +$2.39M | 0.06% | 495 |
|
|
2024
Q1 | $1.46M | Buy |
73,906
+2,356
| +3% | +$46.5K | 0.03% | 772 |
|
|
2023
Q4 | $1.25M | Sell |
71,550
-5,273
| -7% | -$92.5K | 0.03% | 736 |
|
|
2023
Q3 | $1.33M | Sell |
76,823
-9,273
| -11% | -$161K | 0.03% | 639 |
|
|
2023
Q2 | $1.21M | Buy |
86,096
+45,898
| +114% | +$646K | 0.03% | 695 |
|
|
2023
Q1 | $433K | Sell |
40,198
-25,184
| -39% | -$271K | 0.01% | 1057 |
|
|
2022
Q4 | $979K | Buy |
65,382
+8,572
| +15% | +$128K | 0.03% | 650 |
|
|
2022
Q3 | $729K | Buy |
+56,810
| New | +$729K | 0.03% | 647 |
|